Qiagen (QGEN): Margin dodolan resik

Lambang korporat lan logo Qiagen Corp (QGEN)

Thierry Bernard is confidently leading Qiagen N.V. (QGEN) toward leadership in test automation. Effective management has ensured the model's resilience amid shifting demand, as evidenced by the operationally clean sales margins. The value of 18.20 describes the current status of the metric. The business's success relies on an international staff of biologists who value work-life balance in modern laboratories.

Qiagen N.V. (QGEN) - Margin resik saka 04.07.2022 nganti 20.11.2026

Rincian metrik komprehensif lan analitis Qiagen Corp (QGEN)

- nilai pasar lan prakiraan target analis:
Ringkesan analisis perusahaan:qiagen.com - QGEN
Barang unggulan Qiagen Group

Qiagen N.V. (QGEN) maintains its ability to preserve profits during downturns due to inelastic demand for diagnostics and the success of new clinical developments. By analyzing the net profit margin, an investor assesses the portion of revenue converted into net income after all expenses, providing an objective measure of the asset's quality and its resilience against market volatility.

Analisis pesaing

TEM: Margin dodolan resik|Ionis (IONS) - Margin dodolan resik|Margin resik Repligen|Avidity (RNA) - Margin dodolan perusahaan|Margin dodolan resik CRSP|Margin dodolan perusahaan GeneDx|Margin resik Ultragenyx RARE|Margin dodolan perusahaan Beam Therapeutics (BEAM)|SRPT: Rentabilitas dodolan miturut bathi resik|Margin resik Twist Bioscience|TXG (10x Genomics) - Rentabilitas dodolan miturut bathi resik|Intellia Therapeutics, Inc. (NTLA) - Margin dodolan resik|Margin resik Stoke Therapeutics Inc|BLFS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik WVE (Wave Life Sciences Corp)|Margin dodolan perusahaan Maze Therapeutics Corp|Sionna Therapeutics Inc - Rentabilitas dodolan miturut bathi resik|PRME (primemedicine.com) - Margin bathi resik|TSHA - Margin resik|QURE (uniQure) - Rentabilitas dodolan resik|MeiraGTx Corp (MGTX) - Margin resik|Regenxbio - Tingkat bathi resik|Margin resik solidbio.com|Margin resik ocugen.com OCGN|Margin dodolan resik PACB|Benitec - Rentabilitas dodolan resik|Margin resik Design Therapeutics DSGN|Margin dodolan resik Rocket Pharmaceuticals RCKT|Margin bathi resik 4D Molecular Corp|LXEO: Margin resik|KRRO (Korro Bio, Inc) - Rentabilitas dodolan miturut bathi resik|Editas Medicine (EDIT) - Margin dodolan resik|Margin resik Silence Therapeutics Inc.|Rentabilitas dodolan resik PRQR (proqr.com)|Margin resik Codexis Bio (CDXS)|Margin dodolan resik sangamo.com (SGMO)|Margin resik nautilus.bio NAUT|Margin dodolan perusahaan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Margin dodolan resik|GBIO - Margin dodolan resik|BOLD: Margin dodolan resik|Rentabilitas dodolan resik XCUR|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX